Burning Rock Biotech (BNR) Beginning Cash Balance (2020 - 2025)
Historic Beginning Cash Balance for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $63.9 million.
- Burning Rock Biotech's Beginning Cash Balance fell 2709.31% to $63.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $277.0 million, marking a year-over-year decrease of 1884.81%. This contributed to the annual value of $84284.0 for FY2024, which is 3532.58% down from last year.
- Latest data reveals that Burning Rock Biotech reported Beginning Cash Balance of $63.9 million as of Q3 2025, which was down 2709.31% from $72.9 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Beginning Cash Balance registered a high of $327.2 million during Q2 2021, and its lowest value of $63.9 million during Q3 2025.
- In the last 5 years, Burning Rock Biotech's Beginning Cash Balance had a median value of $110.8 million in 2023 and averaged $153.9 million.
- Per our database at Business Quant, Burning Rock Biotech's Beginning Cash Balance surged by 53421.84% in 2021 and then tumbled by 5701.72% in 2023.
- Over the past 5 years, Burning Rock Biotech's Beginning Cash Balance (Quarter) stood at $258.9 million in 2021, then decreased by 19.4% to $208.7 million in 2022, then plummeted by 57.02% to $89.7 million in 2023, then dropped by 23.89% to $68.3 million in 2024, then decreased by 6.36% to $63.9 million in 2025.
- Its Beginning Cash Balance stands at $63.9 million for Q3 2025, versus $72.9 million for Q2 2025 and $72.0 million for Q1 2025.